These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

632 related items for PubMed ID: 22322379

  • 1. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Zhang Y, Wei J, Wang H, Xue X, An Y, Tang D, Yuan Z, Wang F, Wu J, Zhang J, Miao Y.
    Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
    [Abstract] [Full Text] [Related]

  • 2. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
    Kure S, Matsuda Y, Hagio M, Ueda J, Naito Z, Ishiwata T.
    Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
    [Abstract] [Full Text] [Related]

  • 3. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
    Kapucuoğlu N, Bozkurt KK, Başpınar Ş, Koçer M, Eroğlu HE, Akdeniz R, Akçil M.
    Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
    Currie MJ, Beardsley BE, Harris GC, Gunningham SP, Dachs GU, Dijkstra B, Morrin HR, Wells JE, Robinson BA.
    Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia.
    Zhu H, Wang D, Zhang L, Xie X, Wu Y, Liu Y, Shao G, Su Z.
    Oncol Rep; 2014 Sep; 32(3):935-42. PubMed ID: 24994549
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
    Ghuwalewala S, Ghatak D, Das P, Dey S, Sarkar S, Alam N, Panda CK, Roychoudhury S.
    Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
    [Abstract] [Full Text] [Related]

  • 9. Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma.
    Skoda J, Hermanova M, Loja T, Nemec P, Neradil J, Karasek P, Veselska R.
    PLoS One; 2016 Mar; 11(7):e0159255. PubMed ID: 27414409
    [Abstract] [Full Text] [Related]

  • 10. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH, Kim H, Hwang JH, Shin E, Lee HS, Hwang DW, Cho JY, Yoon YS, Han HS, Cha BH.
    Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
    [Abstract] [Full Text] [Related]

  • 11. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
    Yao J, An Y, Wie JS, Ji ZL, Lu ZP, Wu JL, Jiang KR, Chen P, Xu ZK, Miao Y.
    Swiss Med Wkly; 2011 Apr; 141():w13208. PubMed ID: 21630164
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
    Kagara N, Huynh KT, Kuo C, Okano H, Sim MS, Elashoff D, Chong K, Giuliano AE, Hoon DS.
    Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
    [Abstract] [Full Text] [Related]

  • 13. [CD133 promotes the invasion and metastasis of gastric cancer via epithelial-mesenchymal transition].
    Cai C, Yu JW, Wu JG, Lu RQ, Ni XC, Wang SL, Jiang BJ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):662-7. PubMed ID: 23888452
    [Abstract] [Full Text] [Related]

  • 14. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis.
    Ding Q, Miyazaki Y, Tsukasa K, Matsubara S, Yoshimitsu M, Takao S.
    Mol Cancer; 2014 Jan 27; 13():15. PubMed ID: 24468059
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM, Kim HJ, Kim EJ, Chung YR, Yun S, Seo AN, Lee HJ, Park SY.
    Breast Cancer Res Treat; 2014 Aug 27; 147(1):39-49. PubMed ID: 25086633
    [Abstract] [Full Text] [Related]

  • 18. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY, Hu FW, Yu CC, Tsai LL, Yu CH, Wu BC, Chen YW, Huang PI, Lo WL.
    Oral Oncol; 2013 Jan 27; 49(1):34-41. PubMed ID: 22892238
    [Abstract] [Full Text] [Related]

  • 19. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC, Chao YJ, Tung HL, Wang HC, Shan YS.
    Cancer; 2014 Sep 01; 120(17):2766-77. PubMed ID: 24839953
    [Abstract] [Full Text] [Related]

  • 20. Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.
    Du Z, Qin R, Wei C, Wang M, Shi C, Tian R, Peng C.
    Dig Dis Sci; 2011 Mar 01; 56(3):741-50. PubMed ID: 20683663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.